LBC
AVNS

Lowe Brockenbrough & Co’s Avanos Medical AVNS Stock Holding History

Lowe Brockenbrough & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,216
Closed -$237K – 194
2014
Q4 		$237K Buy
+5,216
New +$205K 0.04% 182

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Lowe Brockenbrough & Co's AVNS Position: Q1 2015 in Review

Lowe Brockenbrough & Co sold out of Avanos Medical (AVNS) in Q1 2015, closing a stake of 5,216 shares — an estimated $237K sold.

Lowe Brockenbrough & Co first reported a position in AVNS in Q4 2014 and held it in 1 quarter. The position peaked at $237K in Q4 2014. 448 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

  • Lowe Brockenbrough & Co reported no remaining Avanos Medical position as of Q1 2015 after selling out during the quarter.
  • Lowe Brockenbrough & Co sold 5,216 Avanos Medical shares in Q1 2015, an estimated $237K.
  • Lowe Brockenbrough & Co first reported a position in Avanos Medical in Q4 2014 and held it in 1 quarter.
  • Lowe Brockenbrough & Co's Avanos Medical position peaked at $237K in Q4 2014.
  • 448 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2015, filed 14 May 2015.